Antisense inhibition of δ-opioid receptor gene function in vivo by peptide nucleic acids

Molecular Pharmacology

Volumn 57, Issue 4, 2000, Pages 725-731

  Fraser, Graeme L ^a   Holmgren, Janna ^c   Clarke, Paul B S ^a   Wahlestedt, Claes ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Karolinska Institutet ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; PEPTIDE NUCLEIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; GENE FUNCTION; LOCOMOTION; MALE; NONHUMAN; NUCLEIC ACID PROBE; PRIORITY JOURNAL; RAT;

EID: 0034115561     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.4.725     Document Type: Article

References (41)

1. Aldrian-Herrada G, Desarménien MG, Orcel H, Boissin-Agasse L, Méry J, Brugidou J and Rabié A (1998) A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res 26:4910-4916.
2. Bilsky EJ, Bernstein RN, Hruby VJ, Rothman HB, Lai J and Porreca F (1996) Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptors in vivo. J Pharmacol Exp Ther 277:491-501.
3. Bonham MA, Brown S, Boyd AL, Brown PH, Bruckenstein DA, Hanvey JC, Thomson SA, Pipe A, Hassman F, Bisi JE, Froehler BC, Matteucci MD, Wagner RW, Noble SA and Babiss LE (1995) An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res 23:1197-1203.
4. Brown SC, Thomson SA, Veal JM and Davis DG (1994) NMR solution structure of a peptide nucleic acid complexed with RNA. Science (Wash DC) 265:777-780.
5. Chen YA, Mestek A, Liu J, Hurley JA and Yu L (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
6. Demidov VV, Potaman VN, Frank-Kamenetskii MD, Egholm M, Burchardt O, Son-nichsen SH and Nielsen PE (1998) Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol 48:1310-1313.
7. Egholm M, Burchardt O, Christensen L, Behrens C, Freier SM, Driver DA, Berg RH, Kim SK, Nordén B and Nielsen PE (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature (Lond) 365:566-568.
8. Evans CJ, Keith DE, Morrison H, Magendzo K and Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science (Wash DC) 258:1952-1955.
9. Faruqi AF, Egholm M and Glazer PM (1998) Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells. Proc Natl Acad Sci USA 95:1398-1403.
10. Flanagan WM, Kothavale A and Wagner HW (1996) Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency. Nucleic Acids Res 24:2936-2941.
11. Fraser GL and Wahlestedt C (1997) Antisense approaches in the study of pain, in Molecular Neurobiology of Pain (Borsook D ed) pp 319-336, IASP Press, Seattle.
12. Good L and Nielsen P (1998) Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat Biowtechnol 16:355-358.
13. Grzanna R, Dubin JR, Dent GW, Ji Z, Zhang W, Ho SP and Hartig PR (1998) Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: Tissue penetration, intracellular distribution and c-fos antisense effects. Mol Brain Res 63:35-52.
14. Hua X-Y, Chen P, Polgar E, Nagy I, Marsala M, Phillips E, Wollaston L, Urban L, Yaksh TL and Webb M (1998) Spinal neurokinin NK1 receptor down-regulation and antinociception: Effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy. J Neurochem 70:688-698.
15. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J Pharmacol Exp Ther 257:1069-1075.
16. Kest B, Lee CE, McLemore GL and Inturrisi CE (1996) An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res Bull 39:185-188.
17. Kieffer BL, Befort K, Gaveriaux-Ruff C and Hirth CG (1992) The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89:12048-12052.
18. Knudsen H and Nielsen PE (1996) Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res 24:494-500.
19. 1A receptor. Neurochem Int 31:349-362.
20. Lima WF and Crooke ST (1997) Binding affinity and specificity of Escherichia coli RNase H1: Impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry 36:390-398.
21. 1-dependent stereotypies and stimulation ofdopamine release in the nucleus accumbens. J Neurosci 11:1585-1576.
22. Mansour A, Fox CA, Akil H and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29.
23. Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF and Freier SM (1992) Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem 267:19954-19962.
24. Negri L, Lattanzi R, Borsodi A, Toth G and Salvadori S (1999) Differential knockdown of δ-opioid receptor subtypes in the rat brain by antisense oligodeoxynucle-otides targeting mRNA. Antisense Nucleic Acid Drug Dev 9:203-211.
25. Nielsen PE, Egholm M, Berg RH and Burchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science (Wash DC) 254:1497-1500.
26. 3 receptor antisense influences dopamine synthesis in rat brain. Neuroreport 6:573-576.
27. Norton JC, Piatyszek MA, Wright WE, Shay JW and Corey DR (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotechnol 14:615-619.
28. Ossipov MH, Kovelowski CJ, Nichols ML, Hruby VJ and Porreca F (1995) Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Pain 62:287-293.
29. Perry-O'Keefe H, Yao X-W, Coull J, Fuchs M and Egholm M (1996) PNA pre-gel hybridization, an alternative to Southern blotting. Proc Natl Acad Sci USA 93: 14670-14675.
30. Pooga M, Soomets U, Hällbrink M, Valkna A, Kulliki S, Rezaei K, Kahl U, Hao J-H, Xu X-J, Wiesenfeld-Hallin Z, Hökfelt T, Bartfai T and Langel U (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 16:857-861.
31. 2 dopamine receptors. Mol Pharmacol 48:730-737.
32. Shah S, Duttaroy A, Chen BT, Carroll J and Yoburn BC (1997) The effect of μ-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation. Brain Res Bull 42:479-484.
33. Stein CA (1996) Phosphorothioate antisense oligodeoxvnucleotides: Questions of specificity. Trends Biotechnol 14:147-149.
34. Taylor RW, Chinnery PF, Turnbull DM and Lightowlers RN (1997) Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 15:212-215.
35. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
36. Tyler BM, McCormick DJ, Hoshall CV, Douglas CL, Jansen K, Lacy BW, Cusack B and Richelson E (1998) Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett 421:280-284.
37. Wahlestedt C, Pich EM, Koob GF, Yee F and Heilig M (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by anlisense oligodeoxynucleotides. Science (Wash DC) 259:528-531.
38. Webb SA and Hurskainen P (1996) Transcription-specific assay for quantifying mRNA: A potential replacement for reporter gene assays. J Biomol Screen 1:119-121.
39. Weidner DA and Busch H (1994) Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNase H cleavage of in vitro synthesized p120 mRNA. Oncol Res 6:237-242.
40. Weiler J, Gausepohl H, Hauser N, Jensen ON and Hoheisel JD (1997) Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays. Nucleic Acids Res 25:2792-2799.
41. Woolf TM, Melton DA and Jennings CGB (1992) Specificity of antisense oligonucleotides in vivo. Proc Natl Acad Sci USA 89:7305-7309.